Holen Sie sich die Stockscreener-App
138.41
1.33%
-1.7909
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$140.20
Offen:
$139.3
24-Stunden-Volumen:
308.55K
Relative Volume:
0.40
Marktkapitalisierung:
$7.44B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$-494.50M
KGV:
-15.01
EPS:
-9.22
Netto-Cashflow:
$137.20M
1W Leistung:
-3.06%
1M Leistung:
+4.20%
6M Leistung:
-15.97%
1J Leistung:
-18.89%
1-Tages-Spanne:
$137.44
$139.62
1-Wochen-Bereich:
$137.44
$148.75
52-Wochen-Spanne:
$125.94
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Vergleichen Sie MASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
138.42 | 7.53B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
107.83 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.47 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.74 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.67 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.30 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Strs Ohio Reduces Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo wants Apple’s bid to erase a $634 million patent-infringement verdict overturned - MacTech.com
Masimo Fights Apple Bid to Undo $634 Million Apple Watch Verdict - Bloomberg Law News
Masimo to Sell Consumer Audio Business to HARMAN for $350 Million - rAVe [PUBS]
Massachusetts Financial Services Co. MA Boosts Holdings in Masimo Corporation $MASI - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Medical Device Connectivity Market is expected to generate a revenue of USD 13.4 Billion by 2032, Globally, at 23.40% CAGR: Verified Market Research® - GlobeNewswire Inc.
Masimo Releases Preliminary Q4 Results - ocbj.com
Masimo (NASDAQ:MASI) Updates Q4 2025 Earnings Guidance - MarketBeat
Owlet Stock Up More Than 82% in the Past 6 Months: Still Worth Buying? - Finviz
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Why Masimo Corporation (3M4) stock is a strong analyst pickPrice Action & AI Based Buy and Sell Signals - ulpravda.ru
Why Masimo Corporation stock is trending among retail tradersDay Trade & Daily Stock Trend Reports - Улправда
How rising interest rates impact Masimo Corporation stockQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - ulpravda.ru
Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch - TipRanks
How to watch Masimo’s talk at the J.P. Morgan 2026 healthcare event - Stock Titan
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - The Globe and Mail
Masimo (NASDAQ:MASI) Reaches New 12-Month LowHere's What Happened - MarketBeat
Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes - Benzinga
MASI (Masimo) Net Interest Income : $-34 Mil (TTM As of Sep. 2025) - GuruFocus
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse - Benzinga
MASI (Masimo) Total Equity : $810 Mil (As of Sep. 2025) - GuruFocus
MASI Stock Price, Forecast & Analysis | MASIMO CORP (NASDAQ:MASI) - Chartmill
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker - Benzinga
Masimo Corporation $MASI Shares Sold by Voya Investment Management LLC - MarketBeat
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets - Finviz
Masimo Corporation stock hits 52-week low at 131.47 USD By Investing.com - Investing.com South Africa
Masimo Corporation stock hits 52-week low at 131.47 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Masimo’s Turnaround Hinges On Healthcare Growth And A Consumer Breakup - Finimize
Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech - Kalkine Media
Apple Seeks To Overturn $634M Masimo Patent Verdict - Law360
Apple Asks Judge to Toss Masimo’s $634 Million Watch-Alerts Win - Bloomberg Law News
Masimo Corporation $MASI Shares Sold by Perpetual Ltd - MarketBeat
Masimo Corporation $MASI Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Corient Private Wealth LLC Sells 17,624 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Masimo stock hits 52-week low at 133.66 USD By Investing.com - Investing.com Nigeria
Masimo stock hits 52-week low at 133.66 USD - Investing.com
Masimo Corporation $MASI Shares Sold by Holocene Advisors LP - MarketBeat
Masimo Corporation $MASI Shares Sold by Liontrust Investment Partners LLP - MarketBeat
Masimo Corporation $MASI Shares Purchased by Bellevue Group AG - MarketBeat
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.07%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):